Journal article icon

Journal article

Optogenetic determination of dynamic and cell-type-specific inhibitory reversal potentials

Abstract:
The reversal potential refers to the membrane potential at which the net current flow through a channel reverses direction. The reversal potential is determined by transmembrane ion gradients and, in turn, determines how the channel's activity will affect the membrane potential. Traditional investigation into the reversal potential of inhibitory ligand-gated ion channels (EInh) has relied upon the activation of endogenous receptors, such as the GABA-A receptor (GABAAR). There are, however, challenges associated with activating endogenous receptors, including agonist delivery, isolating channel responses, and the effects of receptor saturation and desensitization. Here, we demonstrate the utility of using a light-gated anion channel, stGtACR2, to probe EInh in the rodent brain. Using mice of both sexes, we demonstrate that the properties of this optically activated channel make it a suitable proxy for studying GABAAR receptor-mediated inhibition. We validate this agonist-independent optogenetic strategy in vitro and in vivo and further show how it can accurately capture differences in EInh dynamics following manipulations of endogenous ion fluxes. This allows us to explore distinct resting EInh differences across genetically defined neuronal subpopulations. Using this approach to challenge ion homeostasis mechanisms in neurons, we uncover cell-specific EInhdynamics that are supported by the differential expression of endogenous ion handling mechanisms. Our findings therefore establish an effective optical strategy for revealing novel aspects of inhibitory reversal potentials and thereby expand the repertoire of optogenetics.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Publisher copy:
10.1523/jneurosci.1392-23.2024

Authors

More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Pharmacology
Role:
Author
ORCID:
0000-0003-3107-7871
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Pharmacology
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Pharmacology
Role:
Author
ORCID:
0000-0003-2363-2898
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Pharmacology
Role:
Author


More from this funder
Funder identifier:
https://ror.org/029chgv08
Grant:
102364/Z/13/Z
More from this funder
Funder identifier:
https://ror.org/03x94j517
Grant:
MR/S01134X/1
More from this funder
Funder identifier:
https://ror.org/0472cxd90
Grant:
617670
More from this funder
Funder identifier:
https://ror.org/00cwqg982
Grant:
BB/S007938/1
BB/S007938/1


Publisher:
Society for Neuroscience
Journal:
Journal of Neuroscience More from this journal
Volume:
44
Issue:
20
Article number:
e1392232024
Place of publication:
United States
Publication date:
2024-04-11
Acceptance date:
2024-04-03
DOI:
EISSN:
1529-2401
ISSN:
0270-6474
Pmid:
38604778


Language:
English
Keywords:
Pubs id:
1989851
Local pid:
pubs:1989851
Deposit date:
2024-09-18
ARK identifier:

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP